VVOS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Vivos Therapeutics Inc (VVOS) is not a strong buy at the moment for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The lack of positive trading signals, bearish technical indicators, and absence of significant catalysts suggest that this stock does not currently present an optimal entry point.
The stock shows bearish technical indicators with a negatively contracting MACD, RSI in the neutral zone at 37.589, and bearish moving averages (SMA_200 > SMA_20 > SMA_5). Key support is at 1.121, and resistance is at 1.396. The stock has a 50% chance to decrease by 0.5% in the next day and a modest 0.94% increase in the next week.
Revenue increased significantly by 75.73% YoY in Q3 2025, and net income improved by 106.42% YoY, indicating some operational improvements.
No recent news, no significant hedge fund or insider trading trends, and gross margin declined by 7.59% YoY. The stock also lacks any recent congress trading activity or influential endorsements.
In Q3 2025, revenue increased to $6,783,000 (up 75.73% YoY), net income improved to -$5,400,000 (up 106.42% YoY), and EPS improved to -0.49 (up 22.50% YoY). However, gross margin dropped to 52.38%, down 7.59% YoY, indicating potential cost pressures.
No analyst rating or price target changes available.
